Swiss devicemaker Synthes is eyeing 2011 sales growth in the mid-to-high single digit percentage range after posting a 10.2 percent rise in full-year net earnings, Reuters is reporting today.
The American unit of multinational devicemaker Synthes has agreed to divest its Norian subsidiary as part of a settlement related to the conduct of a clinical trial for a bone cement product. The
The U.S. Court of Appeals for the Federal Circuit has reversed parts of a lower court ruling that doubled $5.7 million in damages against Medtronic in a case involving intervertebral implants. Spine